Eli Lilly to sign $2bn deal for AI drug development with Hong Kong biotech
Global pharmaceutical companies are aggressively searching for new medicines in China
معلومات السوق الآنية عبر فئات الأصول
Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.
| المطلع | المنصب | التاريخ | النوع | القيمة |
|---|---|---|---|---|
| Jonsson Patrik | EVP & … | Aug 17 '26 | Sale | 7638150,0 |
| Patrik Jonsson | Officer | Aug 17 '26 | Proposed Sale | 7638150,0 |
| Zakrowski Donald A | SVP, Finance, … | Aug 10 '26 | Sale | 2370020,0 |
| DONALD ZAKROWSKI | Officer | Aug 10 '26 | Proposed Sale | 2371420,0 |
| Hakim Anat | EVP, GC … | Aug 07 '26 | Sale | 5950000,0 |
| Hakim Anat | Officer | Aug 07 '26 | Proposed Sale | 11900000,0 |
| Seymour Melissa | EVP, Global … | Aug 01 '26 | Option Exercise | 0,0 |
| LILLY ENDOWMENT, INC. | Shareholder | Jul 07 '26 | Proposed Sale | 372018600,0 |
| LILLY ENDOWMENT, INC. | Shareholder | Jun 26 '26 | Proposed Sale | 343945450,0 |
| Yuffa Ilya | EVP&Pres, LLY … | Jun 10 '26 | Sale | 2876925,0 |
المصدر: FinViz — قد تكون البيانات متأخرة
أخبار منتقاة بالذكاء الاصطناعي تؤثر على سعر LLY والمشاعر والاتجاه
Global pharmaceutical companies are aggressively searching for new medicines in China
Private-credit cracks, high stock valuations and shaky IPO prospects will curb investors’ enthusiasm.
Eli Lilly & Co. shares dip after HSBC turned bearish on the stock, for the second time in a year, …
Eli Lilly's stock is a bit expensive, even with a bit of a decline this year.
Eli Lilly has recently trailed the S&P 500 Index, though analysts remain confident in its longer-term trajectory.
Eli Lilly shares rose after the Mounjaro maker said it had agreed to acquire biotechnology company Orna Therapeutics for $2.4 …
تحليل متعدد المزودين بالذكاء الاصطناعي